Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 15
2015 54
2016 80
2017 61
2018 44
2019 52
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Results by year
Filters applied: . Clear all
Page 1
Multiple Sclerosis.
Reich DS, Lucchinetti CF, Calabresi PA. Reich DS, et al. N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483. N Engl J Med. 2018. PMID: 29320652 Free PMC article. Review. No abstract available.
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.
Cohen J, Belova A, Selmaj K, Wolf C, Sormani MP, Oberyé J, van den Tweel E, Mulder R, Koper N, Voortman G, Barkhof F; Glatiramer Acetate Clinical Trial to Assess Equivalence With Copaxone (GATE) Study Group. Cohen J, et al. JAMA Neurol. 2015 Dec;72(12):1433-41. doi: 10.1001/jamaneurol.2015.2154. JAMA Neurol. 2015. PMID: 26458034 Clinical Trial.
Pregnancy and Family Planning in Multiple Sclerosis.
Langer-Gould AM. Langer-Gould AM. Continuum (Minneap Minn). 2019 Jun;25(3):773-792. doi: 10.1212/CON.0000000000000745. Continuum (Minneap Minn). 2019. PMID: 31162316 Review.
Glatiramer Acetate: from Bench to Bed and Back.
Arnon R, Aharoni R. Arnon R, et al. Isr Med Assoc J. 2019 Mar;21(3):151-157. Isr Med Assoc J. 2019. PMID: 30905097 Free article. Review.
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
Multiple sclerosis, a treatable disease .
Doshi A, Chataway J. Doshi A, et al. Clin Med (Lond). 2017 Dec;17(6):530-536. doi: 10.7861/clinmedicine.17-6-530. Clin Med (Lond). 2017. PMID: 29196354 Free PMC article. Review.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A. La Mantia L, et al. Cochrane Database Syst Rev. 2016 Nov 24;11(11):CD009333. doi: 10.1002/14651858.CD009333.pub3. Cochrane Database Syst Rev. 2016. PMID: 27880972 Free PMC article. Review.
Update on disease-modifying therapies for multiple sclerosis.
Vargas DL, Tyor WR. Vargas DL, et al. J Investig Med. 2017 Jun;65(5):883-891. doi: 10.1136/jim-2016-000339. Epub 2017 Jan 27. J Investig Med. 2017. PMID: 28130412 Review.
Highly Aggressive Multiple Sclerosis.
Bowen JD. Bowen JD. Continuum (Minneap Minn). 2019 Jun;25(3):689-714. doi: 10.1212/CON.0000000000000731. Continuum (Minneap Minn). 2019. PMID: 31162312 Review.
Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients.
Rommer PS, Zettl UK. Rommer PS, et al. Expert Opin Pharmacother. 2018 Apr;19(5):483-498. doi: 10.1080/14656566.2018.1446944. Epub 2018 Mar 12. Expert Opin Pharmacother. 2018. PMID: 29528247 Review.
275 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page